Search research articles
Contact Us
Filters
Showing results (501-510 of 546) with videos related to
Page
of 55
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2014
Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease
Julien Haroche, Fleur Cohen-Aubart, Jean-François Emile, et al.
Acta Dermato-Venereologica
|
March 19, 2015
Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma
Thomas Jouary, Emeline Kubica, Stéphane Dalle, et al.
Journal of Autoimmunity
|
October 16, 2025
Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)
François Barde, Kevin Chevalier, Paul Decker, et al.
Journal of Hypertension
|
September 1, 2007
Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study
Joël Constans, Christine Germain, Philippe Gosse, et al.
Seminars in Arthritis and Rheumatism
|
February 21, 2023
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis
Victor Genin, Jean-François Alexandra, Hubert de Boysson, et al.
Cancer
|
December 8, 2024
Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study
Iona Campo Le Brun, Séphane Dalle, Laurent Mortier, et al.
Plos One
|
September 13, 2016
Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus
Doua F Azzouz, Gabriel V Martin, Fanny Arnoux, et al.
Clinical Rheumatology
|
June 23, 2021
Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology
Graciela N Gómez, Nicolás Pérez, Andrea Braillard Poccard, et al.
Annals of the Rheumatic Diseases
|
July 5, 2022
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control study
Léo Plaçais, Stéphane Dalle, Olivier Dereure, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study
T Jouary, C Leyral, B Dreno, et al.
Page
of 55
Search research articles
Search
Showing results (501-510 of 546) with videos related to
Sort By:
Page
of 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 26, 2014
Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease
Julien Haroche, Fleur Cohen-Aubart, Jean-François Emile, et al.
Acta Dermato-Venereologica
|
March 19, 2015
Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma
Thomas Jouary, Emeline Kubica, Stéphane Dalle, et al.
Journal of Autoimmunity
|
October 16, 2025
Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)
François Barde, Kevin Chevalier, Paul Decker, et al.
Journal of Hypertension
|
September 1, 2007
Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study
Joël Constans, Christine Germain, Philippe Gosse, et al.
Seminars in Arthritis and Rheumatism
|
February 21, 2023
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis
Victor Genin, Jean-François Alexandra, Hubert de Boysson, et al.
Cancer
|
December 8, 2024
Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational study
Iona Campo Le Brun, Séphane Dalle, Laurent Mortier, et al.
Plos One
|
September 13, 2016
Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus
Doua F Azzouz, Gabriel V Martin, Fanny Arnoux, et al.
Clinical Rheumatology
|
June 23, 2021
Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology
Graciela N Gómez, Nicolás Pérez, Andrea Braillard Poccard, et al.
Annals of the Rheumatic Diseases
|
July 5, 2022
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control study
Léo Plaçais, Stéphane Dalle, Olivier Dereure, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study
T Jouary, C Leyral, B Dreno, et al.
Page
of 55